Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Aspelin

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Lakartidningen|July 2, 2003
[Reduced risk of nepropathy with isoosmolar contrast media]Peter Aspelin
Lakartidningen|April 23, 2004
[The radiologist is a clinical consultant, not a photographer]Peter Aspelin
Lakartidningen|November 23, 2006
[New imaging techniques, new demands. Precised problems and subspecialty competency needed for good results]Peter Aspelin
Journal of the American College of Radiology : JACR|December 6, 2011
Toward providing effective, efficient, and equitable care: how much care can we afford?Peter Aspelin
Lakartidningen|September 28, 2005
[Stop direct advertising for CT and MR screening. Time to tighten up Swedish legislation to stop the American trend from reaching Sweden]Peter Aspelin
Radiation Medicine|January 15, 2005
Nephrotoxicity and the role of contrast mediaPeter Aspelin
Lakartidningen|March 22, 2017
[Contrast agent nephropathy is still a reality]Ulf Nyman, Peter Aspelin
Interventional Cardiology Clinics|June 6, 2017
Contrast Media: History and Chemical PropertiesMichael Buschur, Peter Aspelin
Lakartidningen|February 15, 2017
[Value-based radiology - from efficiency to benefit]Peter Aspelin, Jörgen Nordenström
Children (Basel, Switzerland)|May 28, 2022
Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation-Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. <i>Children</i> 2021, <i>8</i>, 949Ulf Nyman, Peter Aspelin
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Lakartidningen|July 2, 2003
[Reduced risk of nepropathy with isoosmolar contrast media]Peter Aspelin
Lakartidningen|April 23, 2004
[The radiologist is a clinical consultant, not a photographer]Peter Aspelin
Lakartidningen|November 23, 2006
[New imaging techniques, new demands. Precised problems and subspecialty competency needed for good results]Peter Aspelin
Journal of the American College of Radiology : JACR|December 6, 2011
Toward providing effective, efficient, and equitable care: how much care can we afford?Peter Aspelin
Lakartidningen|September 28, 2005
[Stop direct advertising for CT and MR screening. Time to tighten up Swedish legislation to stop the American trend from reaching Sweden]Peter Aspelin
Radiation Medicine|January 15, 2005
Nephrotoxicity and the role of contrast mediaPeter Aspelin
Lakartidningen|March 22, 2017
[Contrast agent nephropathy is still a reality]Ulf Nyman, Peter Aspelin
Interventional Cardiology Clinics|June 6, 2017
Contrast Media: History and Chemical PropertiesMichael Buschur, Peter Aspelin
Lakartidningen|February 15, 2017
[Value-based radiology - from efficiency to benefit]Peter Aspelin, Jörgen Nordenström
Children (Basel, Switzerland)|May 28, 2022
Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation-Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. <i>Children</i> 2021, <i>8</i>, 949Ulf Nyman, Peter Aspelin
Pageof 10